ANET
NTNX
HCAT

Mark B. Templeton

Known title: DirectorCIK: 0001201938

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

Arista Networks (ANET) sees CEO stock sale amid AI focus. Chief executive sold about $34 million of ANET shares, reducing her personal holding. Analysts note the company's growing role in AI‑focused data‑center networking as enterprise AI spending rises. Market commentary also points to interest‑rate concerns that can influence high‑growth tech valuations, reflected in ANET's trailing P/E of 63.8. The stock trades near its 52‑week high, with an average analyst target of $244.

this person other insiders at ANET

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Nutanix Stock Underperforms Market Amid Broker Analysis. Nutanix shares have recently declined more sharply than the broader market, drawing attention from financial analysts. Recent broker reports suggest the stock is a focus for investment strategies, while comparisons with peers like MongoDB and Google highlight its position among value-oriented tech names. The company's trailing P/E of 12.7 and average analyst target of $77.79 provide context for these ongoing discussions.

this person other insiders at NTNX

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 27, 2026

Health Catalyst Included in List of Unprofitable Stocks. Health Catalyst was recently named in a Yahoo Finance article listing unprofitable stocks that may fall short of expectations. The company currently trades near its support level, with an average analyst target of $1.77. This context highlights the ongoing focus on the company's profitability and valuation relative to its peers.

this person other insiders at HCAT

Transaction History

ANET▼ Sell$141K
ANET▼ Sell$101K
ANET▼ Sell$368K
ANET▼ Sell$370K
ANET▼ Sell$41K
ANET▼ Sell$254K
ANET▼ Sell$137K
ANET▼ Sell$197K
ANET▼ Sell$337K
ANET▼ Sell$60K
ANET▲ Buy$0
ANET▲ Buy$0
ANET▲ Buy$0
NTNX▲ Buy$0
ANET▲ Buy$0
ANET▲ Buy$0
ANET▲ Buy$0
ANET▲ Buy—
NTNX▲ Buy$0
ANET▲ Buy$0
ANET▲ Buy$0
ANET▲ Buy$0
ANET▲ Buy$0
NTNX▲ Buy$0
ANET▲ Buy$0
ANET▲ Buy—
NTNX▲ Buy$0
HCAT▲ Buy$0
HCAT▲ Buy$0
ANET▲ Buy$0
ANET▲ Buy$0
ANET▲ Buy$0
ANET▲ Buy$0
HCAT▲ Buy$0
ANET▲ Buy$0
ANET▲ Buy$0
ANET▼ Sell$0
ANET▼ Sell$0
ANET▲ Buy$0
ANET▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.